Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)
Clinical trial NCT00161993 · COMPLETED
Trial details
- NCT number
- NCT00161993
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-06-13
- Primary completion
- 2003-09-24
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.